Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations

Jani, Vinod; Koulgi, Shruti; Uppuladinne, Mallikarjunachari V.N.; Thrigulla, Saket Ram; Gundeti, Manohar; Prasad, Goli Penchala; Kumar, Sanjaya; Narayanam, Srikanth; Sonavane, Uddhavesh; Joshi, Rajendra

doi:10.1016/j.crstbi.2024.100151

Current Research in Structural Biology

2024

DOI: 10.1016/j.crstbi.2024.100151

|View full text |Cite

Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations

Vinod Jani,

Shruti Koulgi,

Mallikarjunachari V.N. Uppuladinne

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Bibliometric analysis of the research publications on AYUSH-64 for COVID-19

Singh,

Sisodia,

Mansoria

et al. 2024

International Journal of Ayurveda Research

View full text Add to dashboard Cite

In India, traditional systems of medicine such as Ayurveda have played a very significant role in the mitigation of COVID-19. AYUSH-64 was one of the main Ayurveda formulations which were used for the management of asymptomatic, mild, and moderate cases of COVID-19. To serve as a resource for future research, we set out to analyze the research articles on AYUSH-64 for COVID-19. In this study, the publications from the year 2019 to 2024, related to AYUSH-64, were searched in the Dimensions database and bibliometrically analyzed with VOSviewer 1.6.19 software. A total of 34 publications were found from 22 journals and 3 preprint platform sources. Chief contribution from 64 authors and 17 organizations was identified, and 17 keywords were used more than 10 times indicating clinical research as the hotspot for AYUSH-64. Overall, this analysis suggests the presence of a limited yet substantial number of good-quality research publications associated with AYUSH-64 for COVID-19. Furthermore, the study highlights the notable level of research collaboration, as evidenced by the strong associations among highly contributing authors.

show abstract

Bibliometric analysis of the research publications on AYUSH-64 for COVID-19

Singh,

Sisodia,

Mansoria

et al. 2024

International Journal of Ayurveda Research

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations

Cited by 1 publication

References 23 publications

Bibliometric analysis of the research publications on AYUSH-64 for COVID-19

Bibliometric analysis of the research publications on AYUSH-64 for COVID-19

Contact Info

Product

Resources

About